Think Tank. Chicago PrEP Implementation
Crowdsourcing strategies for the implementation of long-acting injectable cabotegravir (CAB-LA) for HIV prevention for sexual minority men in Chicago
In Chicago, HIV disproportionately affects sexual minority men (SMM). To reduce HIV incidence among this key population, successful implementation of evidence-based practices is critical. Long-acting injectable cabotegravir (CAB-LA) offers a new form of HIV pre-exposure prophylaxis (PrEP) for prevention. Co-designing implementation strategies will maximize the likelihood of effective implementation of CAB-LA in Chicago. Focused on adolescent and adult SMM with particular attention to Black and Latino populations, this project has partnered with the Chicago Department of Public Health to deploy cutting-edge participatory methods that leverages input from target users in the community. The project address two specific aims:
- To crowdsource innovative ideas to implement CAB-LA into integrated care settings through an innovation tournament
- To operationalize top ideas from the innovation tournament into strategies to implement CAB-LA into integrated care settings through implementation mapping
Achievement of the study aims will produce a menu of partner-informed implementation strategies that will guide CAB-LA integration in Chicago. This approach will provide a framework for participatory methods in HIV prevention and implementation science, as well as center the voice of individuals who will benefit most.
Project Details
- Dates: September 2023-April 2025
- Funding Source: National Institute of Allergy and Infectious Diseases
- Grant Number: Ending the HIV Epidemic Supplement (5P30AI117943-08 center grant)
Contact
- Principal Investigator: Amelia Van Pelt, PhD, MPH
- Co-Investigator: Rinad Beidas. PhD
- Project Staff: Byrd Cook, MPH, Elizabeth Casline, PhD, MSc, Brian Mustanski, PhD